{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/622b8f5080a3a00013890f23/6351e0e695f6ed00127babb6?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"Friday, October 21, 2022","thumbnail_width":200,"thumbnail_height":200,"thumbnail_url":"https://open-images.acast.com/shows/622b8f5080a3a00013890f23/show-cover.png?height=200","description":"<p>An FDA committee has voted to pull a preterm birth prevention drug from the market, which had been approved through its controversial accelerated approval program. A CDC panel recommends providing free COVID vaccines to lower-income children. And a large insurer will now cover some software-based therapies for psychiatric and other conditions. That's on today's episode of Gist Healthcare Daily. </p>","author_name":"Gist Healthcare Daily"}